Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ying Y"" wg kryterium: Autor


Tytuł:
The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p.
Autorzy:
Chen DL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China. .; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China. .
Sheng H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China.
Zhang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China.
Jin Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China.
Zhao BT; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China.
Chen N; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China.
Song K; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China.
Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Oncology, Sun Yat-sen University Cancer Center, No. 651 Dong Feng East Road, Guangzhou, 510060, PR China. .; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, P. R. China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2021 Dec 15; Vol. 20 (1), pp. 166. Date of Electronic Publication: 2021 Dec 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
RNA Interference*
RNA, Circular*
Chemokine CXCL12/*genetics
Discs Large Homolog 1 Protein/*genetics
MicroRNAs/*genetics
Stomach Neoplasms/*genetics
Animals ; Cell Line, Tumor ; Disease Models, Animal ; Disease Progression ; Drug Resistance, Neoplasm ; Gene Knockdown Techniques ; Humans ; Immune Checkpoint Inhibitors ; Mice ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Tumor Escape ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression.
Autorzy:
Qiao ZW; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Jiang Y; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Wang L; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Wang L; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Jiang J; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China.
Zhang JR; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China. .
Mu P; Department of Gynaecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, No.44, Xiaoheyan Road, Shenyang, 110042, Liaoning Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Sep 08; Vol. 21 (1), pp. 1004. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
MicroRNAs/*genetics
Ovarian Neoplasms/*pathology
RNA, Long Noncoding/*genetics
Receptor, Angiotensin, Type 1/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Prognosis ; Receptor, Angiotensin, Type 1/genetics ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
circRNA circFAT1(e2) Elevates the Development of Non-Small-Cell Lung Cancer by Regulating miR-30e-5p and USP22.
Autorzy:
Dong W; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhang H; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
Dai Y; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
Zhou Y; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
Luo Y; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
Zhao C; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
Cao Y; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Du Y; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.
Chen Y; Shanghai TCM-Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China.; Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2021 Apr 02; Vol. 2021, pp. 6653387. Date of Electronic Publication: 2021 Apr 02 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*genetics
MicroRNAs/*genetics
RNA, Circular/*metabolism
Ubiquitin Thiolesterase/*genetics
Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Knockdown Techniques ; Humans ; MicroRNAs/metabolism ; Neoplasm Metastasis ; RNA, Circular/genetics ; Ubiquitin Thiolesterase/metabolism
Czasopismo naukowe
Tytuł:
Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA‑503.
Autorzy:
Sun C; Department of Intensive Care Unit, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Xiao T; Department of Infectious Diseases, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Xiao Y; Department of Ultrasound, 960 Hospital of The Chinese People's Liberation Army, Tai'an Hospital, Tai'an, Shandong 271000, P.R. China.
Li Y; Department of Clinical Laboratory, Jinan Chain Medical Laboratory Co., Ltd., Jinan, Shandong 250000, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2021 Mar; Vol. 23 (3). Date of Electronic Publication: 2021 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Down-Regulation*
Gene Expression Regulation, Neoplastic*
Gene Silencing*
Carcinoma, Hepatocellular/*metabolism
Liver Neoplasms/*metabolism
MicroRNAs/*biosynthesis
Neoplasm Proteins/*biosynthesis
RNA, Long Noncoding/*biosynthesis
RNA, Neoplasm/*biosynthesis
Smoothened Receptor/*biosynthesis
Adult ; Aged ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Female ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Male ; MicroRNAs/genetics ; Middle Aged ; Neoplasm Proteins/genetics ; RNA, Long Noncoding/genetics ; RNA, Neoplasm/genetics ; Smoothened Receptor/genetics
Czasopismo naukowe
Tytuł:
miR‑576‑3p overexpression enhances cisplatin sensitivity of ovarian cancer cells by dysregulating PD‑L1 and cyclin D1.
Autorzy:
Zuo Y; Department of Gynecology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China.
Zheng W; Department of Gynecology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China.
Tang Q; Department of Gynecology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China.
Liu J; Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China.
Wang S; Department of Gynecology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China.
Xin C; Department of Medical Oncology, Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2021 Jan; Vol. 23 (1). Date of Electronic Publication: 2020 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
B7-H1 Antigen/*biosynthesis
Cisplatin/*pharmacology
Cyclin D1/*metabolism
Gene Expression Regulation, Neoplastic/*drug effects
MicroRNAs/*biosynthesis
Ovarian Neoplasms/*metabolism
RNA, Neoplasm/*biosynthesis
B7-H1 Antigen/genetics ; Cyclin D1/genetics ; Female ; Humans ; MicroRNAs/genetics ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Exosomal‑miR‑10a derived from colorectal cancer cells suppresses migration of human lung fibroblasts, and expression of IL‑6, IL‑8 and IL‑1β.
Autorzy:
Wang J; Department of Gastrointestinal Surgery, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Liu Y; Department of Gastrointestinal Surgery, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Li Y; Nuclear Medicine Clinical Laboratory, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Zheng X; Nuclear Medicine Clinical Laboratory, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Gan J; Department of Anesthesiology, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Wan Z; The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Zhang J; The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Liu Y; The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Wang Y; Department of Breast Surgery, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Hu W; The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Li Y; The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Liu Y; The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2021 Jan; Vol. 23 (1). Date of Electronic Publication: 2020 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Movement*
Gene Expression Regulation, Neoplastic*
Colorectal Neoplasms/*metabolism
Exosomes/*metabolism
Fibroblasts/*metabolism
Interleukin-1beta/*biosynthesis
Interleukin-6/*biosynthesis
Interleukin-8/*biosynthesis
Lung/*metabolism
MicroRNAs/*metabolism
Neoplasm Proteins/*biosynthesis
RNA, Neoplasm/*metabolism
Cell Line, Tumor ; Coculture Techniques ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Exosomes/genetics ; Fibroblasts/pathology ; Humans ; Interleukin-1beta/genetics ; Interleukin-6/genetics ; Interleukin-8/genetics ; Lung/pathology ; MicroRNAs/genetics ; Neoplasm Proteins/genetics ; RNA, Neoplasm/genetics
Czasopismo naukowe
Tytuł:
Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Autorzy:
Song LN; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai, 200336, China.
Qiao GL; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai, 200336, China.
Yu J; Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval military Medical University, Shanghai, China.
Yang CM; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai, 200336, China.
Chen Y; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai, 200336, China.
Deng ZF; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai, 200336, China.
Song LH; School of Agriculture and Biology, Shanghai Jiao Tong University, 800, Dongchuan road, Shanghai, 201109, China. .
Ma LJ; Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111, Xianxia Road, Shanghai, 200336, China. .
Yan HL; Department of Laboratory Diagnosis and Reproductive Medical Center, Changhai Hospital, Naval military Medical University, 168, Changhai Road, Shanghai, 200433, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Jun 17; Vol. 39 (1), pp. 114. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Epithelial-Mesenchymal Transition*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Carcinoma, Hepatocellular/*pathology
DNA-Binding Proteins/*metabolism
Liver Neoplasms/*pathology
MicroRNAs/*genetics
RNA, Circular/*genetics
RNA-Binding Proteins/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Cell Movement ; Cell Proliferation ; DNA-Binding Proteins/genetics ; Female ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; RNA-Binding Proteins/genetics ; Survival Rate ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
Autorzy:
Liang Y; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Song X; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Li Y; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Chen B; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Zhao W; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Wang L; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Zhang H; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Liu Y; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Han D; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Zhang N; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Ma T; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Wang Y; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Ye F; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Luo D; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Li X; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Yang Q; Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China. qifengy_.; Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China. qifengy_.
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2020 May 08; Vol. 19 (1), pp. 85. Date of Electronic Publication: 2020 May 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Breast Neoplasms/*pathology
MicroRNAs/*genetics
Polypyrimidine Tract-Binding Protein/*metabolism
RNA, Long Noncoding/*genetics
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Cell Proliferation ; Disease Progression ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Polypyrimidine Tract-Binding Protein/genetics ; Prognosis ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
miR-140-5p targeted FGF9 and inhibited the cell growth of laryngeal squamous cell carcinoma.
Autorzy:
Wang Y; Department of Otolaryngology, Liaocheng People's Hospital and EENT Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng, 252000 Shandong, P.R. China.
Huang Q; Department of Otolaryngology, Liaocheng People's Hospital and EENT Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng, 252000 Shandong, P.R. China.
Li F; Department of Otolaryngology Head and Neck, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, 510080 Guangdong, P.R. China.
Pokaż więcej
Źródło:
Biochemistry and cell biology = Biochimie et biologie cellulaire [Biochem Cell Biol] 2020 Apr; Vol. 98 (2), pp. 83-89. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Fibroblast Growth Factor 9/*metabolism
Laryngeal Neoplasms/*metabolism
MicroRNAs/*metabolism
Squamous Cell Carcinoma of Head and Neck/*metabolism
3' Untranslated Regions ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Disease Progression ; Down-Regulation ; Gene Expression Profiling ; Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł:
Long Noncoding RNA CTC Inhibits Proliferation and Invasion by Targeting miR-146 to Regulate KIT in Papillary Thyroid Carcinoma.
Autorzy:
Liao B; Department of Thyroid Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Liu S; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Scicences, Wuhan University, Wuhan, 430072, China.
Liu J; Department of Thyroid Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Reddy PAK; Department of Thyroid Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Ying Y; Department of Thyroid Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Xie Y; Department of Thyroid Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Wang J; Department of General Surgery, Affiliated Hospital of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China. .
Zeng X; Department of Thyroid Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 12; Vol. 10 (1), pp. 4616. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
RNA Interference*
RNA, Long Noncoding*
MicroRNAs/*genetics
Proto-Oncogene Proteins c-kit/*genetics
Thyroid Cancer, Papillary/*genetics
Animals ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Disease Models, Animal ; Drug Resistance, Neoplasm/genetics ; Humans ; Male ; Mice
Czasopismo naukowe
Tytuł:
MicroRNA‑373 exerts anti‑tumor functions in human liver cancer by targeting Rab22a.
Autorzy:
Ye Y; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Zhang L; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Song Y; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Zhuang J; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Wang G; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Ni J; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Zhang S; Department of Oncology, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Xia W; Department of Nuclear Medicine, The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200000, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2019 Oct; Vol. 20 (4), pp. 3874-3882. Date of Electronic Publication: 2019 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Liver Neoplasms/*genetics
MicroRNAs/*genetics
rab GTP-Binding Proteins/*genetics
Cell Line, Tumor ; Cell Proliferation ; Down-Regulation ; Female ; Hep G2 Cells ; Humans ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Invasiveness/genetics ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Tytuł:
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Autorzy:
Zhou RS; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhang EX; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Sun QF; Stomatological Hospital of Shandong University, Shandong, China.
Ye ZJ; Guangzhou University of Chinese Medicine, Guangzhou, China.
Liu JW; Jinan stomatological hospital, Shandong, China.
Zhou DH; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Tang Y; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China. .; Guangzhou University of Chinese Medicine, Guangzhou, China. .; Lingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Aug 07; Vol. 19 (1), pp. 779. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Gene Regulatory Networks*
Carcinoma, Squamous Cell/*genetics
MicroRNAs/*genetics
RNA, Long Noncoding/*genetics
RNA, Messenger/*genetics
Tongue Neoplasms/*genetics
Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Computational Biology/methods ; Female ; Gene Expression Profiling ; Gene Ontology ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Staging ; Transcriptome
Czasopismo naukowe
Tytuł:
The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.
Autorzy:
Xu J; 1Department of Gynaecology and Obstetrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing Medical University, No. 321 Zhongshan Road, Gulou District, Nanjing, 210008 Jiangsu China.; 2Department of Gynaecology and Obstetrics, Shuyang People's Hospital, Shuyang Hospital Affiliated to Xuzhou Medical University, Suqian, 223600 Jiangsu China.
Wang H; 3Department of Gynaecology and Obstetrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008 Jiangsu China.
Wang H; 1Department of Gynaecology and Obstetrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing Medical University, No. 321 Zhongshan Road, Gulou District, Nanjing, 210008 Jiangsu China.
Chen Q; 4Department of Gynaecology and Obstetrics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000 Jiangsu China.
Zhang L; 3Department of Gynaecology and Obstetrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008 Jiangsu China.
Song C; 5State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, 211100 Jiangsu China.
Zhou Q; 5State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, 211100 Jiangsu China.
Hong Y; 1Department of Gynaecology and Obstetrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing Medical University, No. 321 Zhongshan Road, Gulou District, Nanjing, 210008 Jiangsu China.
Pokaż więcej
Źródło:
Hereditas [Hereditas] 2019 Apr 09; Vol. 156, pp. 11. Date of Electronic Publication: 2019 Apr 09 (Print Publication: 2019).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
RNA Interference*
MicroRNAs/*genetics
Uterine Cervical Neoplasms/*genetics
Zinc Finger E-box-Binding Homeobox 1/*genetics
3' Untranslated Regions ; Adult ; Aged ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Female ; Humans ; Janus Kinase 2/metabolism ; Matrix Metalloproteinase 2/metabolism ; Matrix Metalloproteinase 9 ; Middle Aged ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; STAT3 Transcription Factor/metabolism ; Signal Transduction ; Uterine Cervical Neoplasms/metabolism ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł:
HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
Autorzy:
Dong S; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
Wang R; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
Wang H; Key Laboratory of Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Ding Q; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
Zhou X; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
Wang J; The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Zhang K; The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Long Y; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Lu S; Department of Biochemistry and Molecular Biology, Second Military Medical University, Changsha, China.
Hong T; The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Ren H; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Wong K; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
Sheng X; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
Wang Y; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore. .
Zeng Y; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China. .; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2019 Mar 01; Vol. 38 (1), pp. 110. Date of Electronic Publication: 2019 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Ovarian Epithelial/*pathology
Epithelial-Mesenchymal Transition/*physiology
Gene Expression Regulation, Neoplastic/*physiology
MicroRNAs/*metabolism
Phosphatidylinositol 3-Kinases/*metabolism
RNA, Long Noncoding/*metabolism
Carcinoma, Ovarian Epithelial/genetics ; Carcinoma, Ovarian Epithelial/metabolism ; Female ; Humans ; Kaplan-Meier Estimate ; MicroRNAs/genetics ; Progression-Free Survival ; RNA, Long Noncoding/genetics
Czasopismo naukowe
Tytuł:
MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Autorzy:
Huang Y; Department of Oncology, Shengli Oilfield Central Hospital, Shandong, China.
Xiao W; Department of Magnetic Rsonance Emination, Shengli Oilfield Central Hospital, Shandong, China.
Jiang X; Xunshan Street Health Center, Rongcheng, Weihai, Shandong, China.
Li H; Department of Medical, Shengli Oilfield Central Hospital, Shandong, China.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2019; Vol. 26 (2), pp. 229-237.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Colorectal Neoplasms/*pathology
MicroRNAs/*genetics
Phosphoric Monoester Hydrolases/*metabolism
Apoptosis ; Biomarkers, Tumor/genetics ; Cell Movement ; Cell Proliferation ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Phosphoric Monoester Hydrolases/genetics ; Prognosis ; Survival Rate ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł:
MicroRNA-449a Is Downregulated in Cervical Cancer and Inhibits Proliferation, Migration, and Invasion.
Autorzy:
Wang L; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhao Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xiong W; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ye W; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhao W; Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China, .
Hua Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Pokaż więcej
Źródło:
Oncology research and treatment [Oncol Res Treat] 2019; Vol. 42 (11), pp. 564-571. Date of Electronic Publication: 2019 Oct 02.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
MicroRNAs/*genetics
Uterine Cervical Neoplasms/*genetics
Adult ; Aged ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Tumor Burden ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł:
MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4.
Autorzy:
Tian Y; Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Fu X; Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Li Q; Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Wang Y; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Fan D; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Zhou Q; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Kuang W; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Shen L; Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2018 Dec; Vol. 18 (6), pp. 5603-5613. Date of Electronic Publication: 2018 Oct 22.
Typ publikacji:
Journal Article; Retracted Publication
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Oncogenes*
RNA Interference*
Breast Neoplasms/*genetics
Intracellular Signaling Peptides and Proteins/*genetics
MicroRNAs/*genetics
Nerve Tissue Proteins/*genetics
Animals ; Breast Neoplasms/pathology ; Computational Biology/methods ; Disease Progression ; Female ; Gene Knockdown Techniques ; Humans ; Male ; Mice ; Prognosis
Czasopismo naukowe
Tytuł:
Long non‑coding RNA ferritin heavy polypeptide 1 pseudogene 3 controls glioma cell proliferation and apoptosis via regulation of the microRNA‑224‑5p/tumor protein D52 axis.
Autorzy:
Zhang Y; Geriatric Ward of Neurology, Department of Geriatrics, Institute of Tianjin Geriatrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Li Y; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Wang J; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Lei P; Geriatric Ward of Neurology, Department of Geriatrics, Institute of Tianjin Geriatrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2018 Nov; Vol. 18 (5), pp. 4239-4246. Date of Electronic Publication: 2018 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
RNA Interference*
Glioma/*genetics
MicroRNAs/*genetics
Neoplasm Proteins/*genetics
RNA, Long Noncoding/*genetics
Adult ; Apoptosis/genetics ; Biomarkers ; Cell Line, Tumor ; Cell Proliferation ; Female ; Flow Cytometry ; Genes, Reporter ; Glioma/metabolism ; Humans ; Male ; Neoplasm Proteins/metabolism ; Young Adult
Czasopismo naukowe
Tytuł:
miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.
Autorzy:
Li Y; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Zhang H; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Gong H; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Yuan Y; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Li Y; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Wang C; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Li W; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Zhang Z; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Liu M; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Liu H; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China. .
Chen J; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China. .; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2018 Jul 09; Vol. 37 (1), pp. 141. Date of Electronic Publication: 2018 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Carcinoma, Non-Small-Cell Lung/*genetics
Cortactin/*genetics
Lung Neoplasms/*genetics
MicroRNAs/*genetics
Podosomes/*genetics
3' Untranslated Regions ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Cell Proliferation ; Databases, Genetic ; Gene Expression Profiling ; Humans ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Neoplasm Staging ; RNA Interference ; Signal Transduction ; Wiskott-Aldrich Syndrome Protein/metabolism ; cdc42 GTP-Binding Protein/metabolism
Czasopismo naukowe
Tytuł:
miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression.
Autorzy:
Chen B; Hepatopancreatobiliary Surgery Department, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China.
Zhu A; Hepatopancreatobiliary Surgery Department, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China.
Tian L; The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Xin Y; Thyroid Breast Surgery Department, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China.
Liu X; The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Peng Y; The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Zhang J; The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Miao Y; The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Wei J; The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2018 Jul; Vol. 18 (1), pp. 105-112. Date of Electronic Publication: 2018 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Enzymologic*
Gene Expression Regulation, Neoplastic*
Cell Cycle Proteins/*biosynthesis
MicroRNAs/*metabolism
Pancreatic Neoplasms/*metabolism
Protein Serine-Threonine Kinases/*biosynthesis
Proto-Oncogene Proteins/*biosynthesis
RNA, Neoplasm/*metabolism
Animals ; Apoptosis ; Cell Cycle Proteins/genetics ; Female ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNAs/genetics ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/pathology ; Protein Serine-Threonine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; RNA, Neoplasm/genetics ; Polo-Like Kinase 1
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies